Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Riverview Bancorp
RVSB
$107M
| $2.02M | ﹤0.01% |
246,175
-6,714
| -3% | -$50.3K |
|
|
PTN
3127
Palatin Technologies
PTN
$13.5M
| $2.02M | ﹤0.01% |
2,063
+159
| +8% | +$161K |
|
3128
AXT Inc
AXTI
$5.13B
| $2.02M | ﹤0.01% |
463,128
-4,187
| -0.9% | -$13.4K |
|
|
ATHX
3129
DELISTED
Athersys, Inc. Common Stock
ATHX
| $2.01M | ﹤0.01% |
65,440
+1,508
| +2% | +$49.4K |
|
|
NAGE
3130
Niagen Bioscience
NAGE
$244M
| $2M | ﹤0.01% |
464,513
+18,720
| +4% | +$66.5K |
|
3131
Ring Energy
REI
$349M
| $2M | ﹤0.01% |
757,535
-783
| -0.1% | -$1.54K |
|
3132
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
| $2M | ﹤0.01% |
78,900
+8,045
| +11% | +$196K |
|
3133
South Plains Financial
SPFI
$852M
| $2M | ﹤0.01% |
95,619
+56,793
| +146% | +$1.03M |
|
3134
HBT Financial
HBT
$1.33B
| $1.99M | ﹤0.01% |
+105,020
| New | +$1.79M |
|
|
AMRS
3135
DELISTED
Amyris Inc.
AMRS
| $1.98M | ﹤0.01% |
642,212
+192,972
| +43% | +$715K |
|
|
SRGA
3136
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.98M | ﹤0.01% |
24,106
-1,178
| -5% | -$82.6K |
|
3137
Alpha Metallurgical Resources
AMR
$1.94B
| $1.98M | ﹤0.01% |
218,642
-19,070
| -8% | -$290K |
|
3138
VEON
VEON
$3.9B
| $1.98M | ﹤0.01% |
31,292
-202
| -0.6% | -$12.4K |
|
3139
Pulse Biosciences
PLSE
$3.04B
| $1.98M | ﹤0.01% |
147,279
+6,191
| +4% | +$88.2K |
|
|
ENBL
3140
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
| $1.97M | ﹤0.01% |
196,257
-3,350
| -2% | -$34.1K |
|
|
ACOR
3141
DELISTED
Acorda Therapeutics
ACOR
| $1.97M | ﹤0.01% |
8,034
-458
| -5% | -$116K |
|
3142
Saga Communications
SGA
$62.7M
| $1.96M | ﹤0.01% |
64,317
+6,055
| +10% | +$184K |
|
3143
OptimizeRx
OPRX
$128M
| $1.95M | ﹤0.01% |
190,115
+7,586
| +4% | +$86K |
|
|
NESR
3144
National Energy Services Reunited Corp
NESR
$3.59B
| $1.95M | ﹤0.01% |
213,930
-12,861
| -6% | -$99.4K |
|
3145
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $1.95M | ﹤0.01% |
32,927
-3,927
| -11% | -$236K |
|
3146
Castle Biosciences
CSTL
$984M
| $1.94M | ﹤0.01% |
56,484
+5,287
| +10% | +$129K |
|
|
TNAV
3147
DELISTED
Telenav Inc.
TNAV
| $1.93M | ﹤0.01% |
397,330
-4,293
| -1% | -$20.9K |
|
|
PVLA
3148
Palvella Therapeutics
PVLA
$2.26B
| $1.93M | ﹤0.01% |
6,652
-26
| -0.4% | -$7.21K |
|
3149
Zai Lab
ZLAB
$2.86B
| $1.92M | ﹤0.01% |
46,138
+2,122
| +5% | +$78.3K |
|
|
WORK
3150
DELISTED
Slack Technologies, Inc.
WORK
| $1.92M | ﹤0.01% |
85,276
-6,948
| -8% | -$155K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.